Effect of Low Glycemic Index Diet Versus Metformin on Metabolic Syndrome

Authors Information
Article Notes and Dates
To Cite : Rajabi S, Mazloom Z, Zamani A, Tabatabaee H R. Effect of Low Glycemic Index Diet Versus Metformin on Metabolic Syndrome, Int J Endocrinol Metab. 2015 ;13(4):e23091. doi: 10.5812/ijem.23091.
Copyright: Copyright © 2015, International Journal of Endocrinology and Metabolism. .
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. Diabetes Care. 2003; 26(3): 861-7[PubMed]
  • 2. Cho LW. Metabolic syndrome. Singapore Med J. 2011; 52(11): 779-85[PubMed]
  • 3. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23(5): 469-80[DOI][PubMed]
  • 4. Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 2008; 19(2): 71-84[DOI][PubMed]
  • 5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287(3): 356-9[PubMed]
  • 6. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007; 77(2): 251-7[DOI][PubMed]
  • 7. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F. High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring). 2006; 14(3): 377-82[DOI][PubMed]
  • 8. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation. 2008; 117(6): 754-61[DOI][PubMed]
  • 9. Giugliano D, Ceriello A, Esposito K. Are there specific treatments for the metabolic syndrome? Am J Clin Nutr. 2008; 87(1): 8-11[PubMed]
  • 10. Mahan K, Escott-stump S. Krause's Food, Nutrition& Diet therapy. 2012; : 675-706
  • 11. Radulian G, Rusu E, Dragomir A, Posea M. Metabolic effects of low glycaemic index diets. Nutr J. 2009; 8: 5[DOI][PubMed]
  • 12. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004; 27(2): 538-46[PubMed]
  • 13. Carey MG, Al-Zaiti SS, Liao LM, Martin HN, Butler RA. A low-glycemic nutritional fitness program to reverse metabolic syndrome in professional firefighters: results of a pilot study. J Cardiovasc Nurs. 2011; 26(4): 298-304[DOI][PubMed]
  • 14. Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2013; 23(8): 699-706[DOI][PubMed]
  • 15. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008; 31(12): 2281-3[DOI][PubMed]
  • 16. Taleban FA, Esmaeili M. Glycemic Index of Iranian foods. 1999;
  • 17. Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DC, Truswell AS. Low-glycemic index foods improve long-term glycemic control in NIDDM. Diabetes Care. 1991; 14(2): 95-101[PubMed]
  • 18. Jenkins DJ, Wolever TM, Collier GR, Ocana A, Rao AV, Buckley G, et al. Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr. 1987; 46(6): 968-75[PubMed]
  • 19. Sievenpiper JL, Kendall CW, Esfahani A, Wong JM, Carleton AJ, Jiang HY, et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009; 52(8): 1479-95[DOI][PubMed]
  • 20. Morel Y, Golay A, Perneger T, Lehmann T, Vadas L, Pasik C, et al. Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance. Diabet Med. 1999; 16(8): 650-5[PubMed]
  • 21. Giugliano D, De Rosa N, Di Maro G, Marfella R, Acampora R, Buoninconti R, et al. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care. 1993; 16(10): 1387-90[PubMed]
  • 22. Wollen N, Bailey CJ. Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. Biochem Pharmacol. 1988; 37(22): 4353-8[PubMed]
  • 23. Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P, et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014; 2(2): 116-24[DOI][PubMed]
  • 24. Brand-Miller JC, Holt SH, Pawlak DB, McMillan J. Glycemic index and obesity. Am J Clin Nutr. 2002; 76(1): 281S-5S[PubMed]
  • 25. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB. High glycemic index foods, overeating, and obesity. Pediatrics. 1999; 103(3)[PubMed]
  • 26. Bahadori B, Yazdani-Biuki B, Krippl P, Brath H, Uitz E, Wascher TC. Low-fat, high-carbohydrate (low-glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study. Diabetes Obes Metab. 2005; 7(3): 290-3[DOI][PubMed]
  • 27. Melanson KJ, Summers A, Nguyen V, Brosnahan J, Lowndes J, Angelopoulos TJ, et al. Body composition, dietary composition, and components of metabolic syndrome in overweight and obese adults after a 12-week trial on dietary treatments focused on portion control, energy density, or glycemic index. Nutr J. 2012; 11: 57[DOI][PubMed]
  • 28. Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism. 2001; 50(7): 856-61[DOI][PubMed]
  • 29. Liu Y, Huang C, Ceng C, Zhan H, Zheng D, Han W. Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia. Lipids Health Dis. 2014; 13: 115[DOI][PubMed]
  • 30. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med. 1991; 229(2): 181-7[PubMed]
  • 31. Bouche C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, et al. Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care. 2002; 25(5): 822-8[PubMed]
  • 32. Heilbronn LK, Noakes M, Clifton PM. The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control. J Am Coll Nutr. 2002; 21(2): 120-7[PubMed]
  • 33. Goff LM, Cowland DE, Hooper L, Frost GS. Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2013; 23(1): 1-10[DOI][PubMed]
  • 34. Shah M, Adams-Huet B, Bantle JP, Henry RR, Griver KA, Raatz SK, et al. Effect of a high-carbohydrate versus a high--cis-monounsaturated fat diet on blood pressure in patients with type 2 diabetes. Diabetes Care. 2005; 28(11): 2607-12[PubMed]
  • 35. Sloth B, Krog-Mikkelsen I, Flint A, Tetens I, Bjorck I, Vinoy S, et al. No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet. Am J Clin Nutr. 2004; 80(2): 337-47[PubMed]
  • 36. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond). 2012; 122(6): 253-70[DOI][PubMed]
  • 37. Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, De Rosa N, et al. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol. 1993; 44(2): 107-12[PubMed]
  • 38. Khan HMS, Murtaza G, Usman M, Rasool F, Akhtar M, Qureshi MIM, et al. Evidence based study of side effects of drugs used in the treatment of diabetes mellitus. Afr J Pharm Pharmacol. 2012; 6(24): 1805-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check